Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists; Chemical Biology and Drug Design; Vol. 98, iss. 4
| Parent link: | Chemical Biology and Drug Design Vol. 98, iss. 4.— 2021.— [P. 582-603] |
|---|---|
| Korporacja: | |
| Kolejni autorzy: | , , , , , , , , , , , |
| Streszczenie: | Title screen N-formyl peptide receptors (FPR1, FPR2, and FPR3) play key roles in the regulation of inflammatory processes, and recently, it was demonstrated that FPR1 and FPR2 have a dual role in the progression/suppression of some cancers. Therefore, FPRs represent an important therapeutic target for the treatment of both cancer and inflammatory diseases. Previously, we identified selective or mixed FPR agonists with pyridazinone or pyridinone scaffolds showing a common 4-(bromophenyl)acetamide fragment, which was essential for activity. We report here new pyrazole and pyrazolone derivatives as restricted analogues of the above 6-membered compounds, all exhibiting the same 4-bromophenylacetamide side chain. Most new products had low or absent FPR agonist activity, suggesting that the pyrazole nucleus was not appropriate for FPR agonists. This hypothesis was confirmed by molecular modeling studies, which highlighted that the five-membered scaffold was responsible for a worse arrangement of the molecules in the receptor binding site. |
| Język: | angielski |
| Wydane: |
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1111/cbdd.13913 |
| Format: | Elektroniczne Rozdział |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=666452 |
MARC
| LEADER | 00000naa0a2200000 4500 | ||
|---|---|---|---|
| 001 | 666452 | ||
| 005 | 20250215171910.0 | ||
| 035 | |a (RuTPU)RU\TPU\network\37656 | ||
| 035 | |a RU\TPU\network\36478 | ||
| 090 | |a 666452 | ||
| 100 | |a 20211224d2021 k||y0rusy50 ba | ||
| 101 | 0 | |a eng | |
| 102 | |a US | ||
| 135 | |a drcn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists |f C. Vergelli, A. I. Khlebnikov, L. Crocetti [et al.] | |
| 203 | |a Text |c electronic | ||
| 300 | |a Title screen | ||
| 320 | |a [References: 48 tit.] | ||
| 330 | |a N-formyl peptide receptors (FPR1, FPR2, and FPR3) play key roles in the regulation of inflammatory processes, and recently, it was demonstrated that FPR1 and FPR2 have a dual role in the progression/suppression of some cancers. Therefore, FPRs represent an important therapeutic target for the treatment of both cancer and inflammatory diseases. Previously, we identified selective or mixed FPR agonists with pyridazinone or pyridinone scaffolds showing a common 4-(bromophenyl)acetamide fragment, which was essential for activity. We report here new pyrazole and pyrazolone derivatives as restricted analogues of the above 6-membered compounds, all exhibiting the same 4-bromophenylacetamide side chain. Most new products had low or absent FPR agonist activity, suggesting that the pyrazole nucleus was not appropriate for FPR agonists. This hypothesis was confirmed by molecular modeling studies, which highlighted that the five-membered scaffold was responsible for a worse arrangement of the molecules in the receptor binding site. | ||
| 461 | |t Chemical Biology and Drug Design | ||
| 463 | |t Vol. 98, iss. 4 |v [P. 582-603] |d 2021 | ||
| 610 | 1 | |a электронный ресурс | |
| 610 | 1 | |a труды учёных ТПУ | |
| 610 | 1 | |a agonist | |
| 610 | 1 | |a cancer | |
| 610 | 1 | |a formyl peptide receptor | |
| 610 | 1 | |a inflammation | |
| 610 | 1 | |a neutrophil | |
| 610 | 1 | |a pyrazole | |
| 610 | 1 | |a pyrazolone | |
| 610 | 1 | |a агонист | |
| 610 | 1 | |a рак | |
| 610 | 1 | |a нейтрофилы | |
| 610 | 1 | |a пиразолы | |
| 610 | 1 | |a пиразолон | |
| 610 | 1 | |a воспалительные процессы | |
| 610 | 1 | |a молекулярное моделирование | |
| 701 | 1 | |a Vergelli |b C. |g Claudia | |
| 701 | 1 | |a Khlebnikov |b A. I. |c Chemist |c Professor of Tomsk Polytechnic University |f 1963- |g Andrey Ivanovich |3 (RuTPU)RU\TPU\pers\33927 |9 17500 | |
| 701 | 1 | |a Crocetti |b L. |g Letizia | |
| 701 | 1 | |a Guerrini |b G. |g Gabriella | |
| 701 | 1 | |a Cantini |b N. |g Niccolo | |
| 701 | 1 | |a Kirpotina |b L. N. |g Liliya Nikolaevna | |
| 701 | 1 | |a Shchepyotkin |b I. A. |g Igor Aleksandrovich | |
| 701 | 1 | |a Cilibrizzi |b A. |g Agostino | |
| 701 | 1 | |a Quinn |b M. T. |g Mark | |
| 701 | 1 | |a Rossi |b P. |g Patrizia | |
| 701 | 1 | |a Paoli |b P. |g Paola | |
| 701 | 1 | |a Giovannoni |b M. P. |g Maria Paola | |
| 712 | 0 | 2 | |a Национальный исследовательский Томский политехнический университет |b Инженерная школа новых производственных технологий |b Научно-образовательный центр Н. М. Кижнера |3 (RuTPU)RU\TPU\col\23556 |
| 801 | 2 | |a RU |b 63413507 |c 20211224 |g RCR | |
| 856 | 4 | |u https://doi.org/10.1111/cbdd.13913 | |
| 942 | |c CF | ||